Cass I - Search Results

1

Tertiary cytoreductive surgery in recurrent ovarian cancer: selection criteria and survival outcome.

Karam AK, Santillan A, Bristow RE, Giuntoli R 2nd, Gardner GJ, Cass I, Karlan BY, Li AJ. Karam AK, et al. Among authors: cass i. Gynecol Oncol. 2007 Feb;104(2):377-80. doi: 10.1016/j.ygyno.2006.08.037. Epub 2006 Oct 2. Gynecol Oncol. 2007. PMID: 17014899

2

Effect of combination chemotherapy with cisplatin and cyclophosphamide on human immunodeficiency virus type-1 surrogate markers in a patient with advanced epithelial ovarian cancer.

Fishman DA, Viscarello RR, Cass I, Schwartz PE. Fishman DA, et al. Among authors: cass i. Gynecol Oncol. 1995 Apr;57(1):105-8. doi: 10.1006/gyno.1995.1105. Gynecol Oncol. 1995. PMID: 7705691 Free article.

3

Combination chemotherapy with etoposide, cisplatin, and doxorubicin in mixed müllerian tumors of the adnexa.

Cass I, Resnik E, Chambers JT, Chambers SK, Carcangiu ML, Kohorn EI, Schwartz PE. Cass I, et al. Gynecol Oncol. 1996 Jun;61(3):309-14. doi: 10.1006/gyno.1996.0148. Gynecol Oncol. 1996. PMID: 8641607 Free article.

4

Profound thrombocytopenia in previously treated patients with recurrent ovarian carcinoma receiving topotecan.

Cass I, Kuo DY, Fields AL, Runowicz CD, Goldberg GL. Cass I, et al. Gynecol Oncol. 1998 May;69(2):175-8. doi: 10.1006/gyno.1998.4966. Gynecol Oncol. 1998. PMID: 9600828 No abstract available.

5

Molecular advances in gynecologic oncology.

Cass I, Baldwin RL, Karlan BY. Cass I, et al. Curr Opin Oncol. 1999 Sep;11(5):394-400. doi: 10.1097/00001622-199909000-00013. Curr Opin Oncol. 1999. PMID: 10505778 Review.

6

BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study.

Baldwin RL, Nemeth E, Tran H, Shvartsman H, Cass I, Narod S, Karlan BY. Baldwin RL, et al. Among authors: cass i. Cancer Res. 2000 Oct 1;60(19):5329-33. Cancer Res. 2000. PMID: 11034065

7

Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas.

Cass I, Li AJ, Runowicz CD, Fields AL, Goldberg GL, Leuchter RS, Lagasse LD, Karlan BY. Cass I, et al. Gynecol Oncol. 2001 Jan;80(1):56-61. doi: 10.1006/gyno.2000.6027. Gynecol Oncol. 2001. PMID: 11136570

8

Allelotype of papillary serous peritoneal carcinomas.

Cass I, Baldwin RL, Fasylova E, Fields AL, Klinger HP, Runowicz CD, Karlan BY. Cass I, et al. Gynecol Oncol. 2001 Jul;82(1):69-76. doi: 10.1006/gyno.2001.6176. Gynecol Oncol. 2001. PMID: 11426964

9

Improved survival in women with BRCA-associated ovarian carcinoma.

Cass I, Baldwin RL, Varkey T, Moslehi R, Narod SA, Karlan BY. Cass I, et al. Cancer. 2003 May 1;97(9):2187-95. doi: 10.1002/cncr.11310. Cancer. 2003. PMID: 12712470 Free article.

10

The prognostic significance of thrombocytosis in epithelial ovarian carcinoma.

Li AJ, Madden AC, Cass I, Leuchter RS, Lagasse LD, Karlan BY. Li AJ, et al. Among authors: cass i. Gynecol Oncol. 2004 Jan;92(1):211-4. doi: 10.1016/j.ygyno.2003.09.002. Gynecol Oncol. 2004. PMID: 14751160

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters